Combination of omalizumab and bee venom immunotherapy: does it work?
10.5415/apallergy.2018.8.e2
- Author:
Insu YILMAZ
1
;
Sakine Nazik BAHÇECIOĞLU
;
Murat TÜRK
Author Information
1. Division of Immunology and Allergy, Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Turkey. insu2004@yahoo.com
- Publication Type:Case Report
- Keywords:
Anaphylaxis;
Venom immunotherapy;
Omalizumab
- MeSH:
Anaphylaxis;
Bee Venoms;
Bees;
Humans;
Immunotherapy;
Omalizumab;
Premedication
- From:
Asia Pacific Allergy
2018;8(1):e2-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Bee venom immunotherapy (b-VIT) can be combined with omalizumab therapy in order to suppress systemic reactions developing due to b-VIT itself. Omalizumab acts as a premedication and gains time for the immunotherapy to develop its immunomodulatory effects. However, the combination of omalizumab and b-VIT is not always effective enough. Herein we present a patient in whom successful immunotherapy cannot be achieved with combination of omalizumab to b-VIT.
